H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.5% of adults in Charleston have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Census population 150,227. South Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Charleston clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Charleston storefront.
Fibrin Matrix Therapy Products in Charleston, SC for clinics & physicians. Fibrin matrix therapy supports… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 22.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 9.5% of adults in Charleston have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. fibrin matrix therapy inventory is national; utilization is JM-local.
National Fibrin Matrix Therapy Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 9.5% of adults in Charleston have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Adult obesity in Charleston is 28.7% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 22.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JM / Palmetto GBA, sibling states NC, VA, WV. S.C. Department of Public Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy fibrin matrix therapy elsewhere, use this page as a check: homologous-use language, current Palmetto GBA article IDs, and PLACES 9.5% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 9.5% of adults — 2.5 points below the U.S. 12% figure. Obesity is 28.7%; arthritis is 22.2%. That is place-level BRFSS modeling, not a clinic census and not a Charleston trial.
No. Palmetto GBA writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
City-proper counts are unambiguous and match the URL slug. MSA figures change with OMB delineations and would be easy to get wrong. We would rather under-claim than invent a metro number.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
If you operate in South Carolina and another MAC state, say it on the first call. JM will not port 1:1. We would rather split utilization than watch a sister clinic copy Charleston tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Charleston, SC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Charleston is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Charleston — 2.5 points below the U.S. 12% figure. Planning input, not an outcomes claim.
South Carolina Part B wound biologics follow this contractor (siblings: NC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Charleston. Useful for joint-program math; still needs a diagnosis and privileging.
No Charleston storefront. Joe Bradley is an active practice owner. fibrin matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.